Ropes & Gray advised Novo Nordisk on the transaction. Novo Nordisk announced a multi-year partnership with NanoVation Therapeutics to develop genetic medicines for rare and cardiometabolic...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Verastem Oncology on the deal. Verastem Oncology (Nasdaq: VSTM) announced that the company has entered into a discovery and development collaboration with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised HotSpot Therapeutics on the deal. HotSpot Therapeutics announced an exclusive, worldwide collaboration and option to license agreement with AbbVie for HotSpot’s new class...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised IDRx on the deal. Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to...
You must be a Standard 1 Year member to access this content.
